午夜视频在线播放,久久久无码精品亚洲A片消消乐

香蕉91成人一区二区三区飘花,91精品人妻一区二区三区蜜桃,四川少妇BBw搡BBBB槡BBBB,国产成人91一区二区三区APP

<noscript id="ccccc"><optgroup id="ccccc"></optgroup></noscript>

CN

CN EN

Latest News

Latest News Media Downloads Video Center

Kexing Biopharm's clinical trial application accepted for human interferon α1b inhalation solution
2022-08-19

2022-08-19

On the evening of August 18, 2022, Kexing Biopharm...
Kexing Biopharm's clinical trial application accepted for another dosage form of human interferon α2b
2022-08-15

2022-08-15

On the evening of August 14, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had recently received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Human Interferon α2b Spray" was accepted.
Kexing Biopharm's clinical trial application accepted for "Pegylated Human Granulocyte Colony-stimulating Factor Injection"
2022-08-02

2022-08-02

On the evening of August 1, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had just received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Pegylated Human Granulocyte Colony-stimulating Factor Injection" was accepted.
Kexing Biopharm's conference for reviewing operation and management in first half of 2022and planning key tasks for the second half-year held successfully
2022-08-01

2022-08-01

In the face of the complicated political and economic environment in China and overseas as well as the tough situation in the pharmaceutical industry, Kexing Biopharm proposed the working policy themed as "intensely licensing in new products, firmly promoting R&D and innovation, and proactively creating business in new industries" at the beginning of the year, and continuously followed and implemented the policy in the first half-year.
Phase I clinical trial kick-off meeting of Kexing Biopharm's COVID-19 oral drug SHEN26 Capsule held successfully
2022-07-22

2022-07-22

On July 20, 2022, the phase I clinical trial kick-off meeting of SHEN26 Capsule, a small-molecule oral drug against COVID-19 jointly developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm (688136.SH), and Shenzhen Antiv Pharma Co., Ltd., was successfully held in the Second Affiliated Hospital of Anhui Medical University, indicating the official start of the clinical study for the project.

1 2 3 4 5

Support Hotline

0755-26546500
Online Consultation
QR Code

Scan Code Consultation

亚洲成人无码在线观看 | 国产女人裸体在线观看免费视频 | 日韩欧美丝袜制服一区二区三区 | 91精品人妻互换一区二区 | 午夜福利电影在线观看 | 国产精品久久久久久五月天加勒比 | aaaaaaaa在线观看 | 特级婬片A片AAA毛片A级面粉 | 国产网站在线免费观看 | 91在线无码精品秘入口竹美 | 无码人妻一区二区三区线花季转件 | 国产成人三级精品夜夜骚 | 四川少妇一级毛片免费 | 中文字幕人妻一区二区在线视频 | 少妇无套内谢太紧了A片软件 | 国产一区二区三区三区在线观看 | 国产真实伦子伦老人视频 | 欧美一级不卡一二三 | 亚洲精品成人免费视频网站 | 无码高清视频在线观看 | 久久成人免费电影 | 91性中国毛片潮喷 | AV一区二区三区 | 美女一级片免费看 | 最近中文字幕在线播放中 | 欧美又大又长一区 | 日韩性做爰免费A片AA片 | 强推强插av在线观看 | 91一级A片在线观看国产男女无套内射网站 | 国产无套精品一区二区三区 | 无码人妻一区二区三区免责 | 国内一区二区三区小辣椒 | 日日擼夜夜擼狠狠擼88 | 亂倫近親相姦中文字幕 | 91丨老师丨国产丨地址 | 久久精品无欧美专区一区 | 国产精品偷乱一区二区三区 | 寡妇高潮国产一级毛片 | 小向美奈子乳巨码bd播放 | 91肥熟国产老肥熟女 | 免费黄色片在线视频 |

<nav id="c0cc0"><code id="c0cc0"></code></nav>

<noscript id="c0cc0"></noscript>